trending Market Intelligence /marketintelligence/en/news-insights/trending/Y37ZrMgsJxb6D-lcvyxoWQ2 content esgSubNav
In This List

Report: KKR mulls exit from British life-sciences testing company

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Podcast

Street Talk Episode 87

Blog

A New Dawn for European Bank M&A Top 5 Trends

Blog

Insight Weekly: US banks' loan growth; record share buybacks; utility M&A outlook


Report: KKR mulls exit from British life-sciences testing company

Private equity giant KKR & Co. is working with advisers to evaluate a potential sale of LGC Group, Bloomberg News reported, citing people familiar with the matter.

A sale could bring more than £1 billion for the U.K.-based life-sciences testing company, the people told the news outlet. KKR is in the early stage of deliberations and could still opt against a sale, they added.

KKR acquired LGC from British buyout firm Bridgepoint Advisers Ltd. in a deal completed in 2016. LGC, formerly known as Laboratory of the Government Chemist, was first taken private in 1996.

A KKR spokesman declined to comment, according to Bloomberg.